Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and<unk> . The regimen XELIRI consists of capecitabine and<unk> . It may also be used together with fluorouracil and folinic acid for pancreatic cancer following failure of initial treatment.
Irinotecan
Ifosfamide
Vincristine
Topotecan
Etoposide
Normustine
Trifluridine
Doxorubicin